Orphan Drug or Ineffective Molecule?
August 28, 2007
That is the big question. Does anyone know what happened to B Lymphocyte Stimulator (BLyS)? It seemed to be a promising treatment for CVID and other immunodeficiencies but then disappeared after phase 2 trials a couple of years ago. Was it not effective, did it have horrible side effects, was it not profitable or was it simply dropped so that Human Genome Sciences could spend valuable resources elsewhere? It’s frustrating to know that a treatment for my affliction is out there somewhere and I can’t get it.
Entry Filed under: Common Variable Immunodeficiency(CVID), autoimmune disease, cvid, disease, drug development, immunodeficiency, medicine. .
1 Comment Add your own
Leave a Comment
Some HTML allowed:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <pre> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>
Trackback this post | Subscribe to the comments via RSS Feed
1.
sandrar | September 10, 2009 at 6:56 am
Hi! I was surfing and found your blog post… nice! I love your blog.
Cheers! Sandra. R.